Europe’s chemical recycling requires over €400 billion in cumulative capex to compete with virgin plastics production – who will lead?
LONDON, May 27, 2025 /PRNewswire/ — Despite impending mandates and ambitious corporate targets, chemical recycling in Europe remains nascent today mostly due... Read more.
BrainStorm Secures Key Manufacturing Partnership with Minaris for Upcoming NurOwn® Phase 3b ALS Clinical Trials
NEW YORK, May 27, 2025 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative... Read more.
CMHA National launches flexible mental health training for managers, ready for your LMS
TORONTO, May 27, 2025 /CNW/ – To meet the growing need for mental health training in workplaces, the Canadian Mental Health Association (CMHA), National,... Read more.
CIBC launches in-house AI platform enterprise-wide after successful pilot
Team members saved an estimated 200,000+ hours during pilot phase; full rollout aimed at enabling teams to deliver more for clients TORONTO, May 27, 2025 /CNW/ –... Read more.
MEXC Announces the Listing of Sophon (SOPH) with $40,000 in SOPH and 50,000 USDT Prize Pool
VICTORIA, Seychelles, May 27, 2025 /PRNewswire/ — MEXC, a leading global cryptocurrency exchange, will list Sophon (SOPH) on May 28, 2025 (UTC).To celebrate... Read more.
Ituran Announces New OEM Agreement with Stellantis in South America
AZOUR, Israel, May 27, 2025 /PRNewswire/ — Ituran Location and Control Ltd. (NASDAQ: ITRN), a global leader in vehicle telematics, today announced a new service... Read more.
Military Drone Market worth $22.81 billion in 2030 – Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., May 27, 2025 /PRNewswire/ — The global military drone market will grow from USD 15.80 billion in 2025 to USD 22.81 billion in 2030 at a... Read more.
Phanes Therapeutics announces first patient dosed in clinical study of mavrostobart (PT199) in combination with chemotherapy
SAN DIEGO, May 27, 2025 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development... Read more.
Lupin Announces Presentation of Phase 1 Data on LNP7457 (PRMT5 inhibitor) at the American Society of Clinical Oncology – Annual Meeting 2025
MUMBAI, India, NAPLES, Fla. and CHICAGO, May 27, 2025 /PRNewswire/ — Global pharma major Lupin Limited (Lupin) will present data from its Phase 1a clinical... Read more.
Uranium Royalty Corp. Acquires Royalty on Forum Energy Metals Aberdeen Uranium Project in Canada
VANCOUVER, BC, May 27, 2025 /PRNewswire/ – Uranium Royalty Corp. (NASDAQ: UROY) (TSX: URC) (“URC” or the “Company“) is pleased to announce... Read more.